Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from TransMedics Group

Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May

TransMedics Group and two other mid-cap names just posted dominant performances in Q1, smashing forecasts set by Wall Street analysts.

3 Mid-Cap Medical Stocks Outperforming the Market

3 Mid-Cap Medical Stocks Outperforming the Market

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

Markets Today: Stocks Rally Despite Hawkish Fed Comments

Markets Today: Stocks Rally Despite Hawkish Fed Comments

Morning Markets The S&P 500 Index ( $SPX ) ( SPY ) is up +0.28%, the Dow Jones Industrials Index ( $DOWI ) ( DIA ) up +0.21%, and the Nasdaq 100 Index ( $IUXX ) ( QQQ ) is up +0.77%. Stocks this morning are higher. This is despite...

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Markets Today: Hawkish Fed Comments Weigh on Stocks

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.16%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.04%. Stock index futures this morning are mixed after comments Monday night from Minneapolis Fed President Kashkari dampened hopes that the Fed was done raising interest rates. Also,...

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

TransMedics Group: Q1 Earnings Insights

TransMedics Group (NASDAQ:TMDX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings TransMedics Group reported in-line EPS of $-0.38 versus an estimate of $-0.38.

inkl

Read news from The Economist, FT, and more,
with one subscription

Earnings Outlook For TransMedics Group

Earnings Outlook For TransMedics Group

TransMedics Group (NASDAQ:TMDX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that TransMedics Group will report an earnings per share (EPS) of $-0.38.

TransMedics Receives FDA Premarket Approval for OCS™ DCD Heart Indication

TransMedics Receives FDA Premarket Approval for OCS™ DCD Heart Indication

TransMedics Group, Inc. (NASDAQ: TMDX) received premarket approval (PMA) from U.S. Food and Drug Administration (FDA) for its OCS™ Heart System in favour of use with organs from donors after circulatory death (DCD).

Recap: TransMedics Group Q4 Earnings

Recap: TransMedics Group Q4 Earnings

TransMedics Group (NASDAQ:TMDX) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Minneapolis Fed

HC Wainwright & Co

Builders FirstSource

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

345,569 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play